137 related articles for article (PubMed ID: 15979210)
1. Premorbid effects of APOE on synaptic proteins in human temporal neocortex.
Love S; Siew LK; Dawbarn D; Wilcock GK; Ben-Shlomo Y; Allen SJ
Neurobiol Aging; 2006 Jun; 27(6):797-803. PubMed ID: 15979210
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
[TBL] [Abstract][Full Text] [Related]
4. Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
Lai MK; Tsang SW; Garcia-Alloza M; Minger SL; Nicoll JA; Esiri MM; Wong PT; Chen CP; Ramírez MJ; Francis PT
Neurobiol Dis; 2006 Jun; 22(3):555-61. PubMed ID: 16473016
[TBL] [Abstract][Full Text] [Related]
5. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
7. Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay.
Siew LK; Love S; Dawbarn D; Wilcock GK; Allen SJ
J Neurosci Methods; 2004 Oct; 139(2):153-9. PubMed ID: 15488227
[TBL] [Abstract][Full Text] [Related]
8. Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology.
Proctor DT; Coulson EJ; Dodd PR
J Alzheimers Dis; 2010; 21(3):795-811. PubMed ID: 20634587
[TBL] [Abstract][Full Text] [Related]
9. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
10. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
11. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
12. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype.
Trembath D; Ervin JF; Broom L; Szymanski M; Welsh-Bohmer K; Pieper C; Hulette CM
Acta Neuropathol; 2007 Jan; 113(1):23-31. PubMed ID: 17089130
[TBL] [Abstract][Full Text] [Related]
13. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
Zipser BD; Johanson CE; Gonzalez L; Berzin TM; Tavares R; Hulette CM; Vitek MP; Hovanesian V; Stopa EG
Neurobiol Aging; 2007 Jul; 28(7):977-86. PubMed ID: 16782234
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
15. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
16. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia.
Heffernan JM; Eastwood SL; Nagy Z; Sanders MW; McDonald B; Harrison PJ
Exp Neurol; 1998 Apr; 150(2):235-9. PubMed ID: 9527892
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
18. Influence of APOE genotype and the presence of Alzheimer's pathology on synaptic membrane lipids of human brains.
Oikawa N; Hatsuta H; Murayama S; Suzuki A; Yanagisawa K
J Neurosci Res; 2014 May; 92(5):641-50. PubMed ID: 24446209
[TBL] [Abstract][Full Text] [Related]
19. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
20. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
